Market Cap | 6.37B | P/E | 122.57 | EPS this Y | 21.00% | Ern Qtrly Grth | 1,324.20% |
Income | 50.43M | Forward P/E | 45.12 | EPS next Y | 21.30% | 50D Avg Chg | 1.00% |
Sales | 749.59M | PEG | 2.61 | EPS past 5Y | 0.39% | 200D Avg Chg | 18.00% |
Dividend | N/A | Price/Book | 8.36 | EPS next 5Y | 21.00% | 52W High Chg | - |
Recommedations | 2.70 | Quick Ratio | 2.23 | Shares Outstanding | 77.17M | 52W Low Chg | 134.00% |
Insider Own | 3.99% | ROA | 3.31% | Shares Float | 74.09M | Beta | 0.53 |
Inst Own | 75.85% | ROE | 7.16% | Shares Shorted/Prior | 4.45M/5.57M | Price | 41.06 |
Gross Margin | 73.12% | Profit Margin | 6.92% | Avg. Volume | 814,536 | Target Price | 41.80 |
Oper. Margin | 13.80% | Earnings Date | Feb 1 | Volume | 3,354,415 | Change | 0.00% |
Inovalon Holdings, Inc. provides cloud-based platforms for data-driven healthcare. It operates Inovalon ONE Platform, an integrated, real-time cloud native platform that interconnect with the healthcare ecosystem to aggregate and analyze data in real-time, as well as empowers the application in resulting insights. The company also operates myABILITY software platform, an integrated set of cloud-based applications for providers that offers connectivity, administrative, clinical and quality analysis, management, and performance improvement capabilities to acute, post-acute, and ambulatory point-of-care provider facilities. In addition, it offers advisory, implementation, and support services. The company serves health plans and provider organizations, as well as pharmaceutical, medical device, and diagnostics companies. Its platforms include information of data pertaining to approximately one million physicians; 574,000 clinical facilities; and approximately 332 million individuals and 61 billion medical events. Inovalon Holdings, Inc. was founded in 1998 and is headquartered in Bowie, Maryland. As of November 24, 2021, Inovalon Holdings, Inc. was taken private.
Keybanc | Sector Weight | Aug 25, 21 |
BTIG | Neutral | Aug 20, 21 |
SVB Leerink | Market Perform | Aug 20, 21 |
Keybanc | Overweight | Jul 29, 21 |
SVB Leerink | Outperform | Jul 28, 21 |
Baird | Outperform | May 28, 21 |
SVB Leerink | Outperform | Apr 29, 21 |
Keybanc | Overweight | Apr 29, 21 |
Morgan Stanley | Equal-Weight | Feb 4, 21 |
Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
---|---|---|---|---|---|---|---|---|
Boldt Jonathan R | Chief Financial Offi.. Chief Financial Officer | Nov 19 | Sell | 18.42 | 7,500 | 138,150 | 234,190 | 11/19/20 |
Boldt Jonathan R | Chief Financial Offi.. Chief Financial Officer | Oct 15 | Sell | 26.94 | 16,002 | 431,094 | 242,361 | 10/15/20 |